MrC's Smallcap Sweeps for Nov 2023

[MrContrarian]

Smallcap Sweep. 02-Nov-23
Investment shed of hope

StreaksAI (STK) launch of 'Streaks Companion' AI chatbot allowing for "sophisticated humanlike companionship, mentorship and digital assistant services" CEO trills ""With the launch of Streaks Companion, we are not just delivering a product, but an experience".
Here's a brief demo:
"How do I stop losing my shirt on AIM shares?
Chatbot: "stop getting sucked into story stocks like StreakAI, you shmuck." [SP=1.1 Cap=4m]
Ethernity Networks (ENET) wins $475k contract with Tier 1 military aerospace customer to be paid in Nov and Dec. [SP=3.18 Cap=5m]
Ocean Harvest Technology (OHT) study of OceanFeed shows mortality reduced significantly from 49% to 33% and weight gain in chickens. [SP=9.24 Cap=12m]
Cerillion (CER) wins 5 yr contract, worth an initial €12.4m. [SP=1275 Cap=376m]
Empiric Student Property (ESP) trading: 99% revenue occupancy, LFL av. rent up 10.5%. Guides FY23 EPRA EPS 4p and FY div 3.5p. [SP=85.3 Cap=515m]
X5 Retail (FIVE) acquisition of 71 stores operated by the Amba retail chain in the Khabarovsk Territory. [SP=NA Cap=NA]
Kin and Carta (KCT) FY-July. Outlook - "Assuming no further material headwinds...we expect modest H1'24 growth over H2'23. Whilst visibility of H2'24 is limited, we expect continued modest sequential growth in H2'24. We therefore expect flat to low single digit total net revenue growth in FY24". [SP=107 Cap=190m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 06-Nov-23
Quid Sin

LoopUp (LOOP) will exit its Hybridium business, bought in Oct 2021, to focus on "strongly growing Cloud Telephony business, and not compromised by the requirements of the earlier stage Hybridium business". Exit to save c.€1m and cut debt by same. At the time of the acquisition co said it "brings premium hybrid technology for large scale hybrid communications that is primed for material commercial growth". Hey, ho. Trading broadly in line. [SP=1.9 Cap=4m]
Tintra (TNT) mooted 150p offer rejected by majority of holders. Offerer LRB will now tender for 29.9% of co at 150p. Proposed delisting because it "would be better able to raise the capital it needs to develop the business as a private company". [SP=72.06 Cap=13m]
Ten Lifestyle (TENG) contract expansions, new contracts and new partnership agreements. [SP=87 Cap=73m]
Allergy Therapeutics (AGY) won't need additional funding until end Dec as co cuts costs to eke out cash. Trading broadly in line. [SP=1.45 Cap=69m]
Anglo-Eastern Plantations (AEP) Q1-3 own production of fresh fruit bunches (cont) down 2% by vol. CPO prices are expected to be weak for the remaining part of the year. [SP=680 Cap=268m]
Plexus (POS) £175k contract for commencement and completion during Q2 2024. [SP=15 Cap=15m]
Gulf Marine Services (GMS) hikes FY-Dec EBITDA guidance to $83m to $86m (previously: $77m-$85m). FY24 hiked to and $87m to $95m. [SP=12.4 Cap=126m]
Harland & Wolff (HARL) wins £8.5m barge contract extension from Cory for delivery by H1 2025. [SP=14.4 Cap=25m]
Powerhouse Energy (PHE) another company challenges PHE's EU patent granted 15 Sept. Co considers the Claim to be entirely without merit. [SP=0.27 Cap=11m]

In line: APTA, KITW
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 07-Nov-23
Shite Club

Actual Experience (ACT) goes bust because securing new revenue contracts and significant sales has taken longer than expected. Suspended. [SP=0.45 Cap=1m]
Naked Wines (WINE) weak US makes co set FY rev fall guidance to 12-16% from 8-12%. Adj EBIT now £2-6m from £8-12m. CEO scarpers. Chmn says "My view is that this shortfall is largely to do with execution, which in turn is largely due to Nick Devlin splitting his time across both the role of CEO and US President". [SP=45 Cap=33m]
Kromek (KMK) collaboration agreement with new partner to develop Cadmium Zinc Telluride based detectors for photon counting computed tomography. [SP=5.54 Cap=33m]
XP Power (XPP) placed £43.9m last night at 1150p, an 11% premium! [SP=1032 Cap=204m]
Restaurant Group (RTN) no extra cheese for holders as PizzaExpress owner decides not to make competing offer. [SP=66.3 Cap=511m]
MTI Wireless Edge (MWE) wins order worth $1m over the next 14 months. [SP=34.53 Cap=30m]
Harland & Wolff (HARL) c.$1.5m contract for Harland & Wolff (USA), its first. Co "is very active in building its pipeline of opportunities in the USA". [SP=14.75 Cap=26m]
Nanoco (NANO) two year Joint Development Agreement with Asian chemical customer. "With proof of concept now achieved, the key goal of the JDA is to optimise the material for the performance required by a number of global electronics applications. Once this is successfully delivered, the subsequent stage will involve scale up to industrial production levels during 2026 and 2027." [SP=17.76 Cap=58m]
Intercede (IGP) wins order for over $1.4m, "underpins the Group's revenue for FY24 and creates contracted revenue backlog for FY25". [SP=57 Cap=33m]
Futura Medical (FUM) on the up as M8 Pharmaceuticals takes up rights to extend licensing agreement (currently Brazil and Mexico) to market MED3000 in a further 14 countries in Central and South America. [SP=29.64 Cap=89m] [SP=29.64 Cap=89m]
Galliford Try (GFRD) wins £87m contract to deliver a further phase of the new build-to-rent development in London. [SP=235 Cap=242m]
Induction Healthcare (INHC) FY-Sep rev down 14%, pretax -£2.4m (-£4.5m). Outlook positive apart from continued headwinds with Attend Anywhere renewals but does not have in line guidance. [SP=28 Cap=24m]

In line: KINO, CLCO, LUCE, ZTF, DOTD
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 08-Nov-23
May the farce be with you

Versarien (VRS) slippery supercrock makes £455k placing at 0.275p, a 47% discount, to keep the lights on. [SP=0.55 Cap=2m]
Seeing Machines (SEE) $15m contract to deliver an additional automotive program for an "existing European automotive manufacturer". Glad to know the customer is real. Those made-up ones just don't pay up. Starts 2026. [SP=5.74 Cap=239m]
Reach (RCH) plans 5-6% cost cuts in 2024, cutting 450 jobs. [SP=77.88 Cap=248m]
Smiths News (SNWS) FY-Aug 'ahead of expectations', but only slightly. Adj op profit £38.8m vs £38.3m guided. Adj EPS 10.8p vs f/c 10.3p (Stockopedia). Outlook in line. [SP=48.17 Cap=119m]

In line: STB, FPO, TMO
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 09-Nov-23
Waiter, what's in the soup? "You are."

Home REIT (HOME) sells 153 properties (6.5% of the portfolio by number) for a total of £24m. Properties were in poor condition, largely vacant and requiring significant capital expenditure. [SP=38.05 Cap=301m]
STV (STV) guides FY op profit c.£20m "impacted by weak national TV advertising in Q4 and the related effect on the rate of commissioning in Studios". Q1-3 rev up 30%. Q4 ad rev soft. [SP=NA Cap=NA]
Fusion Antibodies (FAB) guides H1-Sep rev behind current market expectations, at £541k+. Several projects were subject to certain technical challenges. Weak rev offset by stringent cost controls to preserve cash. Outlook - positive spin: "prospects for growth remain positive". [SP=5.25 Cap=3m]
Time Finance (TIME) guides FY24 pretax £5.4m+ cf F/C £5m. [SP=28.72 Cap=27m]
TheWorks (WRKS) warns FY-Mar pre IFRS 16 adj EBITDA only c.£6m. Blames weak demand and a need to maintain a higher level of discounting than envisaged. [SP=40.46 Cap=25m]
Regional REIT (RGL) sells office for £6.25m, 26% above book. [SP=27.45 Cap=142m]
DSW Capital (DSW) guides FY-Mar adj pretax £1.1-1.4m. An upgrade? The higher end remains achievable but is subject to certain M&A deals. Licensees have seen a more normalised level of M&A activity in Aug-Oct. [SP=47 Cap=10m]
Angle (AGL) warns FY23 rev only c.£2.2m cf F/C £3m. Cash in line. Cash runway extended to Q2 2025. [SP=13 Cap=34m]
Libertine (LIB) AGM stmt. update on H1-Sep trading and operations that has no trading data I can see. Cash at hand £0.9m which should last to May. "We are on track with the implementation of further performance and durability enhancements to our intelliGEN™ and HEXAGEN™ platforms. These enhancements are intended to satisfy entry requirements for multiple OEM new product development programmes expected to commence in 2024." [SP=2.5 Cap=4m]
Myanmar Investments (MIL) proposes delisting after flagged consultations. "Realisation of the remaining investments could be some time away and that urgent steps are needed to conserve the Company's cash reserves." [SP=0.05 Cap=2m]
Concurrent Technologies (CNC) launches its highest performance Plug In Card "with enhanced operational performance unlocked using an emerging cooling technology". [SP=69 Cap=59m]

In line: WIN, RWI
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 10-Nov-23
Overture to Twilight of the Dogs (Götterdämmerwarning)

Argentex (AGFX) troubled finco that's just lost both CEO and CFO warns FY-Dec rev and op profit flat ie under market forecasts. Why didn't it warn yesterday when CFO left. Guided rev 28% up in July. What the hell is going on? Reviewing strategy. [SP=60 Cap=68m]
Global Ports Holding (GPH) guides FY-Mar passenger volumes 0.7m ahead of guidance at 12.5m+. [SP=250 Cap=170m]
ValiRx (VAL) agreement with StingRay Bio to investigate a lead series of drug candidates for use in oncology. COE trills: ""It is hugely exciting to have another evaluation agreement commencing, particularly one such as this which has a high pedigree of medicinal chemistry". [SP=12.09 Cap=12m]
Warpaint London (W7L) guides FY-Dec rev £85m+ and pretax over £16m, both ahead of market expectations. [SP=313 Cap=241m]
Physiomics (PYC) get gov't grant for 70% of £196k project. [SP=1.61 Cap=2m]

In line: GFRD
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 13-Nov-23
The Tills are Alive with the Sound of Moolah

Saietta (SED) Indian JV (50% owned) wins £106k order for pilot production over the next 3 months. "Target volumes indicated by the client, subject to further purchase orders, are expected to commence in Q2 2024 generating revenue for Saietta VNA of approximately £12.7 million in the first year of production, with an expected minimum of 60,000 orders over a 5 year period." [SP=20.47 Cap=20m]
Sondrel (SND) wins maiden production order for an ASIC chip. No £££. Included in FY23 F/C. [SP=15.58 Cap=14m]
Cellular Goods (CBX) successful creation of kelp-derived biochar. "Paves the way for carbon dioxide removal credit production and a range of applications in agriculture, environmental restoration and industry." [SP=0.46 Cap=3m]
Develop North (DVNO) starts £500k (max) buyback. [SP=75 Cap=22m]
Avingtrans (AVG) wins 3-4 yr multi-phased order starting this month. Initial value c.$10m. [SP=367.9 Cap=118m]
Harworth (HWG) get planning permission for 800,000 sq. ft of industrial & logistics space at its Skelton Grange site in Leeds. [SP=100 Cap=324m]
Brave Bison (BBSN) c.£4m in new contract wins and renewals over periods up to 24 months. [SP=1.6 Cap=20m]
Biome Technologies (BIOM) risk of two RF div contracts slipping into FY24-Dec. Q1-3 in line. [SP=128.9 Cap=5m]
Cordel (CRDL) boasts that the National Gauging Database contract with Network Rail went live on-time and on-budget. [SP=4.81 Cap=9m]
Good Energy (GOOD) info on launches of new products. [SP=267 Cap=45m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 14-Nov-23
The Flak of dawn

Gear4music (G4M) H1-Sep rev down 6%. Pretax loss £1.9m (£1m). Cuts FY rev guidance to £144m but profit in line. [SP=118.1 Cap=25m]
Fonix Mobile (FNX) AGM stmt - trading comfortably in line with expectations. [SP=192.27 Cap=192m]
Beeks Financial Cloud (BKS) wins $1.3m+ 3 yr contract. [SP=104 Cap=68m]
Fintel (FNTL) two acquisitions. Trading in line. [SP=207 Cap=215m]
Billington (BILN) guides FY-Dec rev and pretax ahead of market expectations. [SP=320 Cap=41m]
Byotrol (BYOT) post CEO departure review leads to co warning H1-Sep rev only flat at £2m and EBITDA loss £0.45m (£0.3m). Blames impact of discontinued items (due to expected regulatory changes and to reduce complexity). Guides FY rev £3.9m (£4.3m or £3.7m excluding discontinued items). Cash is tight "but is sufficient to finance current operations" with cost cutting [SP=0.86 Cap=4m]
DP Poland (DPP) Q3 Total System sales up 7% and 14% LFL, down from prev Q growth. Oct strong at up 33%. CEO excitedly comments "It's fantastic to see the business begin to capitalise on the potential of the markets we operate in, but this is only the beginning, and we expect performance to continue improving". [SP=8.5 Cap=57m]
Kanabo (KNB) contract extension for its online telehealth platform, The GP Service. Client is a "leading UK retail business, a provider of health and beauty retail and e-pharmacy services". [SP=1.2 Cap=8m]
Rotala (ROL) PUSU offer deadline extended to 12 Dec. [SP=56.25 Cap=18m]
Revolution Beauty (REVB) H1-Aug rev up 20%. Pretax £0.4m (-£13.7m). Current trading in line with internal forecasts. Material uncertainty going concern stmt. [SP=27.65 Cap=88m]
Castings (CGS) H1-Sept. Guides FY marginally ahead of market expectations. [SP=378 Cap=164m]
Allergy Therapeutics (AGY) Phase III trial to evaluate efficacy and safety of hayfever vaccine meets primary endpoint. [SP=1.49 Cap=71m]

In line: CBOX
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 20-Nov-23
Pain reaction

Velocys (VLS) mooted rescue offer of 0.25p, a 66% discount. "Board recognises that it should assess the Proposal as a whole in light of the Company's very near-term funding requirements and significant long-term funding needs." [SP=0.68 Cap=11m]
musicMagpie (MMAG) re speculation: early-stage discussions with both BT and Aurelius on a possible offer. [SP=18.78 Cap=20m]
McBride (MCB) AGM stmt - continues to trade ahead of mgmt expectations in Oct and Nov. [SP=52 Cap=90m]
Develop North (DVNO) £500k max buyback. [SP=75 Cap=22m]
Ilika (IKA) reaches design-freeze milestone for first customer prototype release of Goliath battery. Will deliver batteries for testing over 6 months. [SP=29.5 Cap=47m]
RUA Life Sciences (RUA) strategy review 18 months ago has "dramatically reduced the future funding requirements". Gets Bid Request for a product range for RUA's implantable textiles with possible rec £1.5m PA. [SP=15.24 Cap=3m]
Mercia Asset Management (MERC) sale of stake in nDreams for £30.2m, split £26.4m cash and £3.8m re-invested into the buyer, Aonic. That's £4.4m above book. Net cash now c.£60m. [SP=22.2 Cap=99m]
MTI Wireless Edge (MWE) Q1 to Q3 rev down 3%, pretax up 6%"helped by positive currency movements and margin improvement". Outlook sounds OK despite the Israel situation. [SP=32.53 Cap=29m]
Cerillion (CER) FY-Sept. No current trading fig but outlook strong. [SP=1300 Cap=383m]

In line: BEG, SNR, SRT
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 21-Nov-23
Wood you believe it, Accsys warns again

Accsys Technologies (AXS) H1-Sept rev up 21%, adj pretax -€5m (-€0.56m). Warns FY24 below market expectations due to continued weak demand. [SP=63 Cap=139m]
Tern (TERN) insults holders by keeping CEO removed as director by AGM vote as a non-board CEO although he will not make investment or strategy decisions. Updates on co's investees. [SP=4.13 Cap=16m]
Videndum (VID) £125m placing at 267p, a 3% discount, to pay back loans. [SP=271.5 Cap=127m]
TruFin (TRU) Letter of Intent to sell IP and assets of its augmented reality and gamification AdTech platform but price is not expected to be significant. [SP=56.5 Cap=60m]
MyCelx Technologies (MYX) has now received the formal Purchase Order for the REGEN contract worth $5.4m. Underpins FY24 rev guidance of $17.5m. [SP=58.5 Cap=13m]
Empresaria (EMR) warns FY adj pretax only £3-3.5m due to weak mkt continuing in Q4 and expected to persist into next H1. [SP=38 Cap=19m]
Intercede (IGP) H1-Sep rev up 15% and ESP up 25%. Guides FY ahead of market expectations as it wins new clients wins in the US, EMEA and APAC regions. [SP=58.06 Cap=34m]
AO World (AO.) recovery under returned founder continues. H1-Sept rev down 12%. Hikes FY pretax guidance to £28-£33m from £28m and rev down 10%. [SP=83.8 Cap=485m]

In line: KGH, SFR, ECK, CLX, TRI
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 22-Nov-23
Cruising for a losing

TT Electronics (TTG) warns FY23 adj pretax towards the lower end of market expectations. Blames previously noted machinery breakdown at Sensors and Specialist Components. [SP=161.6 Cap=285m]
Speedy Hire (SDY) warns FY towards the lower end of mgmt expectations. H1-Sep rev down 3%, adj pretax down 56%. [SP=36.95 Cap=171m]
Pebble (PEBB) warns FY-Dec rev expected to be c. £124m (£134m) due to poor order intake at Brand Addition. [SP=85 Cap=142m]
Plant Health Care (PHC) warns FY-Dec rev flat to modest growth and FY24 rev c.28% lower than market expectations of $23m. Blames "lower levels of inventory being maintained by the Company's distributors and regulatory delays in some territories". USA weak. [SP=5.9 Cap=20m]
Science (SAG) guides FY-Dec rev miss but adj op profit in line. Blames "global economic and geopolitical climate with investment by clients in consumer and industrial sectors". That's just about everything then. Cautious on the outlook for FY24. [SP=400 Cap=182m]
Accrol (ACRL) guides FY-Apr adj EBITDA £21m+ cf F/C £20.5m. CItes strong margin recovery. Expects adj net debt close to 1x EBITDA by FY end. [SP=29.6 Cap=94m]
SIgmaRoc (SRC) monster €745m acquisition and placing. £200m placing at 47.5p, a 5% discount, to part finance buying lime biz from CRH. Classed at RTO. Suspension. [SP=50.2 Cap=348m]
Quadrise (QED) successful industrial demonstration test of MSAR and bioMSAR fuels at client's site in Morocco. Discussions for long-term commercial supply. [SP=1.17 Cap=18m]

In line: IDOX, GTLY
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 23-Nov-23
Pre-owned news

Motorpoint (MOTR) H1-Sept rev down 23%. Pretax -£3.7m (+£3m). Market: "the value of used cars, which has fallen since the end of the period, with a reduction in wholesale values of c.6% in just the last six weeks. Whilst we have taken proactive measures to limit the impact on our stock, the current environment is likely to be volatile as new car supply into the used car market begins to increase". [SP=77.7 Cap=70m]
Macfarlane (MACF) guides FY23 adj pretax in line. Jan-Oct rev down 2% with weaker volumes and lower pricing impacting most sectors. Co "does not expect trading conditions to substantially improve in the near term". [SP=110.47 Cap=176m]
Windward (WNWD) €3,2m five-year contract with a European national coastguard. Paid up front. Co trading comfortably in line with market expectation. [SP=66.8 Cap=57m]
Intelligent Ultrasound (IUG) launch of new gestational age estimation AI software, Also sells four ScanNav FetalCheck systems in Africa. [SP=9.3 Cap=30m]
Horby (HRN) H1-Sept rev up 6%. "Order book is strong and although, like everyone, we are seeing the ramp up into Christmas trade coming later than in previous years, we are starting to see some encouraging increases in performance." [SP=15 Cap=25m]

In line: MBH, DX., CNSL, VLX
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 27-Nov-23
Frontier on the back foot (geddit?)

Frontier Developments (FDEV) another games developer warns FY24 rev likely to be only £80-95m cf F/C £108m due to weak slaes of new Warhammer game. However market expectation for an adj EBITDA loss of c. £9m remains achievable towards the upper-end of rev guidance. Expects at least break even in FY25. Chmn scarpers after only 12 months. [SP=196 Cap=77m]
CPP (CPP) sells its majority interest in Globiva for c.£5.1m because it's non-core. [SP=143.89 Cap=13m]
Gfinity (GFIN) sells remaining 27.5% interest in Athlos Game Technologies for £260k due to ongoing losses. [SP=0.07 Cap=2m]
Revolution Beauty (REVB) re speculation: remains in negotiation on both potential legal proceedings against ex CEO Adam Minto and with Tom Allsworth, the previous owner of Medichem, to reach a revised agreement on the terms of its acquisition. [SP=30.25 Cap=96m]
Quadrise (QED) AGM stmt - review of project progress. [SP=1.38 Cap=21m]
Concurrent Technologies (CNC) guides FY-Dec rev ahead of market expectations of £27m. H2 rev expected to be substantially higher than any prior half-year. Confident of of material revenue growth next FY too. [SP=72 Cap=62m]
Live Company (LVCG) bricking it as overall creditors remains in the region of £3-4m despite costs cuts. Looking at cutting of non-performing business and the addition of new verticals. Bricklive has entered into an outsourcing agreement with Iconic Bricks so that Bricklive now a sales only biz. FY22 accounts still not ready. Co is aware of all regulatory timetables". [SP=2.08 Cap=5m]
RIghtmove (RMV) the mkt bellweather states rev since July marginally ahead of consensus expectations, despite uncertainty in the housing market. [SP=507.47 Cap=4078m]

In line: EPWN, ZIN
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 28-Nov-23
Wading through the overflow of announcements

Journeo (JNEO) guides FY-Dec rev c.£46m, ahead of market expectations due to strong Fleet Operator Systems and Passenger Information Systems businesses. Expects adj pretax £3.9m, ahead of exp. [SP=217 Cap=36m]
Crossword Cybersecurity (CCS) warns FY-Dec rev £4.1-£4.3, cf £6m guided. Blames delayed contracts. Pretax loss broadly in line due to cost control. Cuts FY24 rev guidance to £7m from £8m. [SP=9.67 Cap=9m]
Clean Power Hydrogen (CPH2) terminates contract with ATOME Energy for a single 1MW MFE220 electrolyser placed in March 2022. Co to focus "its engineering and installation resources in ensuring roll out MFEs with current partners Fabrum Solutions Limited, KCA Deutag and their longstanding customer, Northern Ireland Water". [SP=13.47 Cap=36m]
Good Energy (GOOD) guides FY-Dec pretax £4m+, ahead of mgmt exp due to strong trading. [SP=342 Cap=58m]
ATOME Energy (ATOM) see CPH2 news. "The former mobility project is now seen as a diversion from ATOME's core focus on delivering industrial scale green fertiliser." [SP=74.8 Cap=30m]
Fusion Antibodies (FAB) collaboration agreement with the National Cancer Institute for the use of OptiMAL in the discovery of novel antibodies against targets. [SP=3.4 Cap=2m]
Crimson Tide (TIDE) guides FY-Dec rev in line but EBITDA £0.4m+ significantly ahead of mgmt expectation. Pretax loss £0.7m. Market exp is rev £6.2m and adj EBITDA £0.2m. [SP=142 Cap=9m]
Home REIT (HOME) agreement with Eden Safe for the surrender of its leases on 38 properties. HOME has had no rent since Oct 22. [SP=38.05 Cap=301m]
Sopheon (SPE) PUSU deadline extended to 26 Dec. [SP=893 Cap=95m]
Augmentum Fintech (AUGM) H1-Sept NAV/sh after performance fee up 0.8% to 160.2p over the half. Chmn whines that the "share price does not reflect the tangible value creation we have seen across our top 10 investments and their potential for further growth." [SP=84.53 Cap=144m]
Vp (VP.) H1-Sep. Guides FY broadly in line with market expectations. [SP=649.55 Cap=261m]
Topps Tiles (TPT) (FY-Sep. Outlook - "Softer build into the seasonal peak trading period. Sales down 3% in first eight weeks and Topps Tiles LFL down 6.1%. Strong growth continuing in Pro Tiler Tools. [SP=46.02 Cap=90m]
Supreme (SUP) H1-Sep. Hikes FY rev guidance to £210 - 225m (previously guided £195 - 205m) and adj EBITDA c.£32 - 35m, £4.5m ahead of guidance. [SP=110 Cap=129m]

In line: ENSI, DPEU, IGR, KINO, BRCK, TUNE
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 29-Nov-23
Shaking the crap out of news

RM (RM.) get waiver for Nov covenant test. [SP=47.9 Cap=40m]
Holders Technology (HDT) proposes delisting and tender offer for up to 53% of cap at 43p, a 10% premium. [SP=38 Cap=2m]
Transense Technologies (TRT) AGM stmt - first 4 months rev up 13%, below the Board's expectations however it still expects to meet FY exp due to "the short-term order book and opportunity pipeline for both SAWsense and Translogik indicate an upturn in trading". [SP=105.32 Cap=16m]
Xaar (XAR) guides FY23 rev only £70-72m but adj pretax £2.5-3m, ahead of Board expectations due to a favourable product mix and new customer product launches. Expects weaker Q4 demand will continue into 2024 so FY24 will miss rev and adj profit expectations. [SP=173.5 Cap=136m]
EQTEC (EQT) wins $180k US contract for engineering toward waste wood-to-electricity plant. Also agreed price of €300k for front-end engineering design to follow. Possible further €7m work. [SP=0.04 Cap=6m]
Xeros Technology (XSG) guides FY-Dec adj EBITDA in line with market expectations but rev dependent on the timing of a specific XOrb shipment delivery date to one customer. Adj EBITDA would beat exp if this is shipped this FY. F/C is rev £0.8m, adj EBITDA loss £4.7m. Looking at amending warrants to raise cash. [SP=3.15 Cap=5m]
Distribution Finance Capital (DFCH) guides FY-Dec pretax only £2m+ due to expected credit loss provision in relation to RoyaleLife which represents 2% of assets. [SP=26 Cap=47m]
LifeSafe (LIFS) warns FY23 U/L LBITDA £1.3-1.5m, higher than market expectations due to "recent increases in the Group's costs of digital advertising and logistics as the Company has scaled at pace". Jan-Nov rev up 62%. "This extraordinary sales growth has been achieved almost exclusively through the Group's digital consumer channels in the UK and US." Cost cuts. [SP=26.9 Cap=7m]
Silver Bullet Data Services (SBDS) £1m placing at 70p, a 35% smack in the chops, to "provide the working capital required to facilitate the significant recent growth in new contract wins and further accelerate the expansion of the Company's new 4D AI Powered Insights Platform". [SP=112 Cap=18m]
Equals (EQLS) PUSU deadline now 27 Dec. Trading in line. Co has contacted a limited number of potential bidders "o assess whether such parties could put forward a proposal that would deliver greater value to Equals' shareholders than pursuing a standalone independent strategy". [SP=111.98 Cap=208m]
Synectics (SNX) wins £1m order from a major UK financial institution to deliver a multi-site deployment of Synergy. To complete in FY24. [SP=101 Cap=18m]
Halfords (HFD) H1-Sep. Guides FY U/L pretax within a narrower range of £48-53m. "B2B businesses and needs-based categories are continuing to show very strong growth. However, trading patterns have been volatile across the first half of the year, and in the last couple of months we have seen some market softening in our discretionary big-ticket categories" [SP=227 Cap=497m]
Pipehawk (PIP) FY-June. Outlook - "all divisions of the Group are currently performing well". [SP=11.5 Cap=4m]
Plexus (POS) FY-June. Outlook - long winded statement of need for its product but no trading guidance. [SP=22.98 Cap=24m]

In line: RTC, CRU, NTBR
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian